NEW YORK (GenomeWeb News) –The Ben & Catherine Ivy Foundation has awarded the Translational Genomics Research Institute $10 million to conduct genomics research into glioblastoma, TGen announced today.

The funding will support two five-year, $5 million projects: one looking into why some glioblastoma multiforme (GBM) patients survive beyond the average survival time, the other investigating new drugs that might extend the survival of GBM patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.